Ameritas Investment Partners’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Ameritas Investment Partners’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,291	Closed	-$16K	–	3319
2022 Q1	$16K	Hold	12,291	–	–	﹤0.01%	2656
2021 Q4	$16K	Hold	12,291	–	–	﹤0.01%	2750
2021 Q3	$27K	Hold	12,291	–	–	﹤0.01%	2547
2021 Q2	$46K	Hold	12,291	–	–	﹤0.01%	2252
2021 Q1	$40K	Hold	12,291	–	–	﹤0.01%	2219
2020 Q4	$42K	Hold	12,291	–	–	﹤0.01%	2085
2020 Q3	$50K	Buy	12,291 +2,792	+29%	+$10.6K	﹤0.01%	1841
2020 Q2	$32K	Hold	9,499	–	–	﹤0.01%	2099
2020 Q1	$22K	Hold	9,499	–	–	﹤0.01%	2132
2019 Q4	$35K	Hold	9,499	–	–	﹤0.01%	2119
2019 Q3	$79K	Hold	9,499	–	–	﹤0.01%	1621
2019 Q2	$82K	Buy	9,499 +1,085	+13%	+$9.71K	﹤0.01%	1632
2019 Q1	$90K	Hold	8,414	–	–	﹤0.01%	1544
2018 Q4	$74K	Hold	8,414	–	–	﹤0.01%	1585
2018 Q3	$141K	Hold	8,414	–	–	0.01%	1321
2018 Q2	$176K	Buy	8,414 +1,054	+14%	+$19.5K	0.01%	1145
2018 Q1	$118K	Hold	7,360	–	–	0.01%	1393
2017 Q4	$139K	Buy	7,360 +1,310	+22%	+$23.7K	0.01%	1301
2017 Q3	$59K	Hold	6,050	–	–	﹤0.01%	1784
2017 Q2	$45K	Hold	6,050	–	–	﹤0.01%	1976
2017 Q1	$39K	Buy	+6,050	New	+$33.8K	﹤0.01%	2007

Other funds holding SPPI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Ameritas Investment Partners's SPPI Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2022, closing a stake of 12,291 shares — an estimated $16K sold.

Ameritas Investment Partners first reported a position in SPPI in Q1 2017 and held it in 21 quarters. The position peaked at $176K in Q2 2018. 86 funds tracked by Wall St. Rank hold SPPI as of Q2 2022.

Ameritas Investment Partners reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 12,291 Spectrum Pharmaceuticals Inc shares in Q2 2022, an estimated $16K.
Ameritas Investment Partners first reported a position in Spectrum Pharmaceuticals Inc in Q1 2017 and held it in 21 quarters.
Ameritas Investment Partners's Spectrum Pharmaceuticals Inc position peaked at $176K in Q2 2018.
86 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.